Moexipril detailed information

Moexipril detailed information
Clinical data
Pregnancy; category	US: D (Evidence of risk) ; ;
Routes of; administration	Oral
ATC code	C09AA13 (WHO) ;
Legal status
Legal status	UK: POM (Prescription only) ; US: ℞-only ;
Identifiers
	IUPAC name (3S)-2-[(2S)-2-[ [(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid;
CAS Number	103775-10-6;
PubChem CID	91270;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C27H34N2O7
Molar mass	498.568 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Moexipril (marketed under the tradenames Univasc and Perdix) is an ACE inhibitor.

Clinical data

Pregnancy category	US: D (Evidence of risk)
Routes of administration	Oral
ATC code	C09AA13 (WHO)
Legal status
Legal status	UK: POM (Prescription only) US: ℞-only
Identifiers
IUPAC name (3S)-2-[(2S)-2-[ [(2S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-6,7-dimethoxy-3,4-dihydro-1H-isoquinoline-3-carboxylic acid
CAS Number	103775-10-6
PubChem CID	91270
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₂₇H₃₄N₂O₇
Molar mass	498.568 g/mol

Navigation menu